Hairy cell leukemia: short review, today's recommendations and outlook

Hairy cell leukemia (HCL) is part of the low-grade non-Hodgkin lymphoma family and represents approximately 2% of all leukemias. Treatment with splenectomy and interferon-α historically belonged to the first steps of therapeutic options, achieving partial responses/remissions (PR) in most cases with...

Descripción completa

Detalles Bibliográficos
Autores principales: Maevis, V, Mey, U, Schmidt-Wolf, G, Schmidt-Wolf, I G H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944661/
https://www.ncbi.nlm.nih.gov/pubmed/24531447
http://dx.doi.org/10.1038/bcj.2014.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944661/
https://www.ncbi.nlm.nih.gov/pubmed/24531447
http://dx.doi.org/10.1038/bcj.2014.3

Ejemplares similares